Improving Marginal Likelihood Estimation for Bayesian Phylogenetic Model Selection

Por Xie, Wangang, Lewis, Paul O., Fan, Yu, Kuo, Lynn, Chen, Ming-Hui
Publicado em 2011

Posterior Predictive Bayesian Phylogenetic Model Selection

Por Lewis, Paul O., Xie, Wangang, Chen, Ming-Hui, Fan, Yu, Kuo, Lynn
Publicado em 2014

A Bayesian Approach to Pathway Analysis by Integrating Gene–Gene Functional Directions and Microarray Data

Por Zhao, Yifang, Chen, Ming-Hui, Pei, Baikang, Rowe, David, Shin, Dong-Guk, Xie, Wangang, Yu, Fang, Kuo, Lynn
Publicado em 2011

Resistance Analysis of Baseline and Treatment-Emergent Variants in Hepatitis C Virus Genotype 1 in the AVIATOR Study with Paritaprevir-Ritonavir, Ombitasvir, and Dasabuvir

Por Krishnan, Preethi, Tripathi, Rakesh, Schnell, Gretja, Reisch, Thomas, Beyer, Jill, Irvin, Michelle, Xie, Wangang, Larsen, Lois, Cohen, Daniel, Podsadecki, Thomas, Pilot-Matias, Tami, Collins, Christine
Publicado no Antimicrob Agents Chemother (2015)

In Vitro and In Vivo Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A

Por Krishnan, Preethi, Beyer, Jill, Mistry, Neeta, Koev, Gennadiy, Reisch, Thomas, DeGoey, David, Kati, Warren, Campbell, Andrew, Williams, Laura, Xie, Wangang, Setze, Carolyn, Molla, Akhteruzzaman, Collins, Christine, Pilot-Matias, Tami
Publicado no Antimicrob Agents Chemother (2015)